Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
emerging markets
Pharma
Glenmark, Hengrui ink $1.1B deal for HER2 ADC
Both the Hengrui ADC and Enhertu use trastuzumab as the antibody guide and an exatecan derivative as the toxic payload.
Angus Liu
Sep 24, 2025 10:16am
Novartis expands collaboration with Shanghai Pharma in China
May 27, 2025 10:08am
AstraZeneca CEO defends $80B revenue target amid China probes
Nov 12, 2024 9:40am
UPDATED: AstraZeneca stock tanks over fears of more China probe
Nov 5, 2024 3:13pm
Biocon's Peter Bains jumps from the board to group CEO
Sep 19, 2023 9:20am
AZ's China head refutes news report about potential spinoff
Jun 20, 2023 10:20am
